Basis of Presentation and Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Fair Value Measurement Specific to Assets or Liability

	Fair Value Measurements at Reporting Date Using (in thousands)
	Balances as of September 30, 2023		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents:
Money market funds	$	15,606	$	15,606	$	—	$	—
U.S. Treasuries	$	85,666	$	85,666	$	—	$	—
Investment in equity securities:
Equity securities	$	12,897	$	12,897	$	—	$	—
	Balances as of December 31, 2022		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents:
Money market funds	$	168,853	$	168,853	$	—	$	—
U.S. Treasuries	$	105,442	$	105,442	$	—	$	—

Basic and Dilutive Weighted Average Common Shares

The following table reconciles basic and diluted weighted average common shares:

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Basic weighted average common shares outstanding		106,568,137		103,318,572		106,133,077		102,967,280
Effect of dilutive securities		—		8,667,453		7,618,293		7,384,934
Diluted weighted average common shares outstanding		106,568,137		111,986,025		113,751,370		110,352,214

Summary of Disaggregated Product Revenue

The following table summarizes the Company’s net product revenue disaggregated by product (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
FIRDAPSE®	$	66,224	$	57,173	$	188,648	$	153,255
FYCOMPA®		36,393		—		98,750		—
Total product revenue, net	$	102,617	$	57,173	$	287,398	$	153,255